Acadia pharmaceuticals announces promotion of mark schneyer to executive vice president, chief financial officer

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad) today announced the promotion of mark schneyer to executive vice president, chief financial officer (cfo), effective immediately. mr. schneyer has served as the company's interim cfo since september 2021, while retaining his responsibilities as acadia's head of business development and chief business officer. mr. schneyer's responsibilities as cfo will include the functional areas of finance, accounting, investor relations,
ACAD Ratings Summary
ACAD Quant Ranking